Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 3217Carcinoma, Non-Small-Cell Lung 2731Breast Neoplasms 2553Colorectal Neoplasms 1464Prostatic Neoplasms 1310Neoplasm Metastasis 1302Multiple Myeloma 1112Melanoma 1102Ovarian Neoplasms 1006Lung Neoplasms 946Recurrence 924Leukemia, Myeloid, Acute 878Pancreatic Neoplasms 833Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 693Carcinoma, Renal Cell 661Carcinoma, Hepatocellular 648Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 516Head and Neck Neoplasms 491Glioblastoma 473Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 436Advanced Solid Tumors 433Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Safety Issues × Clear all
NCT05142592 2025-09-24

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Nanjing Immunophage Biotech Co., Ltd

Phase 1/2 Recruiting
196 enrolled

Safety Issues

NCT05580172 2022-10-17

Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer

ReHeva Biosciences,Inc.

Phase 1 Unknown
6 enrolled

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon âš¡